Search

Search Constraints

You searched for: Author/Creator Demirhan, Yunus Emre

Search Results

2. S318 Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP. (October 2021)